FORGOTTEN HISTORY: Linzess - The Untold Story

Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating

Ironwood Pharmaceuticals rose 30% after a strategic price cut on Linzess unlocked higher revenue guidance and surprised Wall Street analysts.

MarketBeat · Jan 7

2 Under-the-Radar Pharmaceutical Stocks to Add to Your Watchlist

Irrespective of worsening supply chain disruptions due to the Russia-Ukraine war, the pharmaceutical industry is expected to witness stable growth given the rising medical needs of an aging population and rapid advancements in the drug development process. So, amid an apparent resurgence of COVID-19 cases, we think it could be…

StockNews.com · Apr 22, 2022

Jefferies Raises Price Target On This Small-Cap 'Stand Out' Biotech Stock

Ardelyx Inc (NASDAQ:ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst Chris Howerton thinks Ardelyx "stands out" given that the Company has an approved IBS-C product, Isbrela, that will launch in April and whose commercial…

Benzinga · Mar 2, 2022